The Gene Panel Market is being driven by rapid developments in next-generation sequencing, precision medicine, and clinical genomic testing.

One of the most significant trends is the shift from traditional single-gene sequencing toward targeted panels capable of analyzing dozens or hundreds of genes simultaneously. This approach provides healthcare professionals with broader genetic information while supporting efficient diagnostic workflows.

According to Market Research Future, amplicon-based approaches accounted for 65.46% of the market in 2025 because of their speed, cost efficiency, and suitability for multi-gene cancer testing. Hybridization-based approaches are also expected to expand as demand grows for larger panels requiring comprehensive coverage.

Artificial intelligence is another important trend. AI-assisted variant interpretation can help laboratories process genetic data more efficiently and reduce the workload associated with manual variant classification.

Pharmacogenetics is expected to be one of the fastest-growing applications, supported by increasing interest in preemptive genetic testing and personalized medication decisions.

The market is also benefiting from declining sequencing costs, growing cancer incidence, government-backed genomics programs, and increased adoption of molecular diagnostics in hospitals and reference laboratories.